Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease

[1]  Günther Deuschl,et al.  MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[2]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[3]  V. Myllylä,et al.  Cardiovascular reflexes in Parkinson's disease. , 1987, European neurology.

[4]  B. Pompe,et al.  Permutation entropy: a natural complexity measure for time series. , 2002, Physical review letters.

[5]  M. Hallett,et al.  Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation , 2007, Neurology.

[6]  A. Porta,et al.  Early Abnormalities of Vascular and Cardiac Autonomic Control in Parkinson’s Disease Without Orthostatic Hypotension , 2007, Hypertension.

[7]  Andrés Machado,et al.  Automatic Filtering of R‐R Intervals for Heart Rate Variability Analysis , 2000 .

[8]  Wolfgang Hamm,et al.  Bedside autonomic risk stratification after myocardial infarction by means of short-term deceleration capacity of heart rate. , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  M. Sabaté,et al.  Time and frequency domain analysis for the assessment of heart autonomic control in Parkinson's disease. , 1996, Journal of neural transmission.

[10]  Inflammatory profile in LRRK2-associated prodromal and clinical PD , 2016, Journal of Neuroinflammation.

[11]  D. Goldstein,et al.  Dysautonomia in Parkinson's disease: neurocardiological abnormalities , 2003, The Lancet Neurology.

[12]  Niels Wessel,et al.  Classifying cardiac biosignals using ordinal pattern statistics and symbolic dynamics , 2012, Comput. Biol. Medicine.

[13]  Herbert F. Jelinek,et al.  How to Calculate Renyi Entropy from Heart Rate Variability, and Why it Matters for Detecting Cardiac Autonomic Neuropathy , 2014, Front. Bioeng. Biotechnol..

[14]  R. Wurster,et al.  Cardiac Responses during Stimulation of the Dorsal Motor Nucleus and Nucleus Ambiguus in the Cat , 1980, Circulation research.

[15]  D. Standaert,et al.  LRRK2 Inhibition Attenuates Microglial Inflammatory Responses , 2012, The Journal of Neuroscience.

[16]  D. Berg,et al.  Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson’s disease , 2015, Journal of Neural Transmission.

[17]  Phyllis K Stein,et al.  Sometimes Higher Heart Rate Variability Is Not Better Heart Rate Variability: Results of Graphical and Nonlinear Analyses , 2005, Journal of cardiovascular electrophysiology.

[18]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[19]  Martin J. McKeown,et al.  The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study , 2018, The Lancet Neurology.

[20]  A. Porta,et al.  Effects of mechanical stimulation of the feet on gait and cardiovascular autonomic control in Parkinson's disease. , 2014, Journal of applied physiology.

[21]  A. Lang,et al.  Parkinson's disease , 2015, The Lancet.

[22]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[23]  C. Ross,et al.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Lang,et al.  Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers , 2011, Neurology.

[25]  G. Halliday,et al.  Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers , 2016, Movement disorders : official journal of the Movement Disorder Society.

[26]  Alberto Porta,et al.  Limits of permutation-based entropies in assessing complexity of short heart period variability , 2015, Physiological measurement.

[27]  A. Teixeira,et al.  Circulatory responses at the onset of handgrip exercise in patients with Parkinson's disease , 2019, Experimental physiology.

[28]  P N Karnauchow,et al.  Accuracy of clinical diagnosis. , 1982, Canadian Medical Association journal.

[29]  Kwang-Soo Lee,et al.  Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease , 2016, Journal of movement disorders.

[30]  J. Trojanowski,et al.  Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. , 2015, JAMA neurology.

[31]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[32]  C. Tanner,et al.  Heart rate variability in leucine‐rich repeat kinase 2‐associated Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.

[33]  Mika P.  Tarvainen,et al.  How to Calculate Renyi Entropy from Heart Rate Variability, and Why it Matters for Detecting Cardiac Autonomic Neuropathy , 2014, Front. Bioeng. Biotechnol..

[34]  Herbert F. Jelinek,et al.  A Comparison of Nonlinear Measures for the Detection of Cardiac Autonomic Neuropathy from Heart Rate Variability , 2015, Entropy.

[35]  Phyllis K. Stein,et al.  Development of more erratic heart rate patterns is associated with mortality post-myocardial infarction. , 2008, Journal of electrocardiology.

[36]  R. Freeman,et al.  Diabetic autonomic neuropathy. , 2003, Diabetes care.

[37]  J. Zarranz,et al.  Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. , 2013, Parkinsonism & related disorders.

[38]  U. Tolonen,et al.  Heart rate variability in patients with untreated Parkinson’s disease , 2000, European journal of neurology.

[39]  Manuel Rodriguez,et al.  Time and frequency domain analysis for the assessment of heart autonomie control in Parkinson's disease , 2005, Journal of Neural Transmission.

[40]  Steven F. Maier,et al.  Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication , 1995, Neuroscience Letters.

[41]  L. Wilkins.  Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers , 2011, Neurology.

[42]  N. Eriksson,et al.  Heart Rate Variability in LRRK2 Parkinson’s Disease (S37.004) , 2014 .

[43]  P. S. St George-Hyslop,et al.  LRRK2 gene in Parkinson disease , 2005, Neurology.

[44]  M. Malik,et al.  Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study , 2006, The Lancet.

[45]  P. Stein.  Vagal Tone: Myths and Realities , 2005, Journal of cardiovascular electrophysiology.